Robert Chen
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.5%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lymphoma Diagnosis and Treatment 83
- Oncology 62
- Viral-associated cancers and disorders 25
- CAR-T cell therapy research 17
- HER2/EGFR in Cancer Research 14
- Co-authors
- Ajay K. Gopal (15 shared papers)Craig H. Moskowitz (9 shared papers)Scott E. Smith (10 shared papers)Joseph D. Rosenblatt (7 shared papers)Stephen Maxted Ansell (8 shared papers)Anas Younes (8 shared papers)Joseph M. Connors (7 shared papers)Andres Forero‐Torres (14 shared papers)
- Journals
- Blood (37 papers)Transplantation and Cellular Therapy (7 papers)Journal of the National Comprehensive Cancer Network (4 papers)Journal of Clinical Oncology (4 papers)The Oncologist (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert Chen
94 papers receiving 6.9k citations
Robert Chen's Hit Papers
Peers
Comparison fields: 5 of 99
- Pathology and Forensic Medicine 4.4k
- Oncology 4.1k
- Genetics 1.2k
- Neurology 1.4k
- Immunology 1.2k
Countries citing papers authored by Robert Chen
This map shows the geographic impact of Robert Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Chen more than expected).
Fields of papers citing papers by Robert Chen
This network shows the impact of papers produced by Robert Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Chen. The network helps show where Robert Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma Hit paper breakdown → | 2012 | 1212 |
| 2 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma Hit paper breakdown → | 2017 | 818 |
| 3 | Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma Hit paper breakdown → | 2017 | 593 |
| 4 | 2016 | 320 | |
| 5 | 2009 | 297 | |
| 6 | 2019 | 270 | |
| 7 | 2017 | 247 | |
| 8 | 2015 | 185 | |
| 9 | 2014 | 181 | |
| 10 | 2016 | 155 | |
| 11 | 2014 | 151 | |
| 12 | 2012 | 130 | |
| 13 | 2020 | 122 | |
| 14 | 2015 | 116 | |
| 15 | 2015 | 115 | |
| 16 | 2000 | 111 | |
| 17 | 2012 | 104 | |
| 18 | 2022 | 88 | |
| 19 | 2013 | 87 | |
| 20 | 2019 | 85 |
About Robert Chen
Robert Chen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 96 papers that have together received 7.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (83 papers), Viral-associated cancers and disorders (25 papers), Chronic Lymphocytic Leukemia Research (20 papers), CAR-T cell therapy research (17 papers), HER2/EGFR in Cancer Research (14 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (12 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.4k citations), Oncology (4.1k citations), Genetics (1.2k citations), Neurology (1.4k citations) and Immunology (1.2k citations). Robert Chen has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ajay K. Gopal, Craig H. Moskowitz, Scott E. Smith, Joseph D. Rosenblatt, Stephen Maxted Ansell, Anas Younes, Joseph M. Connors, Andres Forero‐Torres, Emily K. Marino Larsen and Andreas Engert. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of the National Comprehensive Cancer Network, Journal of Clinical Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.